Citation
M. Ohta et al., ANALYSIS OF HEPATIC VEIN WAVE-FORM BY DOPPLER ULTRASONOGRAPHY IN 100 PATIENTS WITH PORTAL-HYPERTENSION, The American journal of gastroenterology, 89(2), 1994, pp. 170-175
Abstract
Objectives: We classified the Doppler waveform seen in patients with p
ortal hypertension and examined the associations of the waveform type
with the diagnosis of Budd-Chiari syndrome and severity of the liver c
irrhosis. Methods: The Doppler pattern of right and left hepatic veins
in 100 consecutive Japanese patients with portal hypertension and eso
phagogastric varices was classified into six types: I, triphasic wavef
orm; II, biphasic waveform without reversed flow; III, decreased ampli
tude of phasic oscillations; IV, flat waveform with fluttering; V, com
pletely net waveform with fluttering; VI, no waveform. All patients un
derwent computed tomography and magnetic resonance imaging. Patients i
n whom hepatic vein waveform showed type IV, type V, or type VI, posit
ively underwent hepatic venography and inferior vena cavography. Resul
ts: Type I was seen in 31 of 100 patients, type II in 35, type III in
17, type IV in eight, type V in four, and type VI in five. Types I-IV
waveform indicated no lesion in hepatic veins and inferior vena cave,
type V indicated stenosis of hepatic veins or occlusion of inferior ve
na cava, and type VI, occlusion of hepatic veins. For one patient with
type V hepatic veins, balloon angioplasty was done, and the waveform
changed from type V to type II. Examining the relationship between hep
atic vein waveform and the Child-Pugh score, liver function of type IV
cases was worse than that of type I cases in 66 cirrhotic patients wi
thout hepatocellular carcinoma(p < 0.05). There was no clear relations
hip between hepatic vein waveform and portal venous perfusion, as base
d on Nordlinger's grade. Conclusions: Our classification of hepatic ve
in waveform in Doppler ultrasonography is useful in diagnosing Budd-Ch
iari syndrome, in judging the efficiency of treatment for hepatic vein
lesions, and in assessing severe liver function in cirrhotic patients
.